MedTrace Logo

Stratification of the Acute Respiratory Distress Syndrome

NCT02288949 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-10-12

No results posted yet for this study

Summary

The American-European Consensus Conference (AECC) and the Berlin definitions of the Acute Respiratory Distress Syndrome (ARDS) could be adequate for epidemiologic studies, but it is not adequate for inclusion of patients into therapeutic clinical trials. Despite recent reports on the effects of standardized ventilator settings on PaO2/FIO2 and fulfillment of AECC and Berlin definitions of ARDS, it is still a matter of debate whether the assessment of hypoxemia at 24 hours is the most appropriate tool for stratifying lung severity in patients with ARDS. The investigators will perform an observational, multicenter, prospective audit in a network of intensive care units in Spain and China for validating and confirming that the assessment of hypoxemia at 24 hours after ARDS onset is the most valuable tool for stratifying and predicting outcome in patients with ARDS.

Conditions

  • Acute Respiratory Distress Syndrome (ARDS)

Interventions

OTHER

stratification

Patients will be stratified based on the values of relevant demographics, pulmonary and systemic variables in relation to mortality in the intensive care unit.

Sponsors & Collaborators

  • Asociación Científica Pulmón y Ventilación Mecánica

    collaborator OTHER

  • Dr. Negrin University Hospital

    lead OTHER

Principal Investigators

  • Jesús Villar, MD, PhD · Hospital Universitario Dr. Negrin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02288949 on ClinicalTrials.gov